Has Bryan Caldwell received payments from drug or device companies?

Yes. Drug and device makers reported $8,362 in general payments to Bryan Caldwell across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bryan Caldwell did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bryan Caldwell come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bryan Caldwell

Podiatrist · Cleveland, OHNPI 1366448680

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,475 of the $8,362 with a category attached, or 65.5%. Melinta Therapeutics, LLC accounts for 70.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $3,338 and has fallen 92.6% since, to $247 in 2025. Among podiatrist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,362in general payments, 2019–2025

Across 104 payments — averaging $80.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Melinta Therapeutics, LLC$6K
Medtronic$623
Smith+Nephew$419
Amgen$298
GRT US Holding, Inc.$190
AbbVie$175
plus $756 from 14 others

What the payments were for

Speaking & faculty fees$5,47565%
Travel & lodging$551%
Food & beverage$2,83234%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Melinta Therapeutics, LLC	13	$5,901
Medtronic	51	$623
Smith+Nephew	8	$419
Amgen(2 entities)	4	$298
GRT US Holding, Inc.	5	$190
AbbVie	3	$175
Convatec Inc.	2	$163
Organogenesis Inc.	1	$107
Paratek Pharmaceuticals, Inc.	1	$82
Kerecis Limited	2	$60
Boston Scientific	1	$59
Bioventus LLC	3	$58
Mimedx Group, Inc.	1	$43
Linvatec Corporation	1	$43
Nevro Corp.	2	$32
Orthofix Medical, Inc.	2	$31
Averitas Pharma Inc.	1	$22
Integra Lifesciences Corporation	1	$20
Osteomed LLC	1	$17
Dynasplint Systems Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,362 in reported general payments places this provider in the 90th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciclopirox	13	$409
Ammonium Lactate	18	$247

Paid to pharmacies, not to this prescriber.

Other podiatrist in Cleveland

Michael MaierCleveland$120K
James HayesCleveland$31K
Nathan RossiCleveland$31K
Brendan JohnsonCleveland$9K
Mark HardyAvon$2.1M
Lawrence DidomenicoBoardman$1.1M
Ralph NapolitanoNew Albany$494K
Thomas GronerNiles$193K
Eric StortsLondon$101K
Daniel LoganGahanna$83K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →